`

Artiva Biotherapeutics

Biotechnology Research

Specialities :
Cell therapy
Cancer
Nk cells
Nk cell therapy
And car-nk
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$120.0M
size-icon Size
51 - 200

Frequently Asked Questions About Artiva Biotherapeutics

What does Artiva biotherapeutics do?+

Artiva Biotherapeutics is an immunotherapy company with the ability to produce off-the-shelf, allogeneic NK cell therapies at a massive scale. Our mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. Our lead program, AlloNK, is an allogeneic, non-genetically modified NK cell therapy candidate designed to enhance the activity of monoclonal antibodies or NK cell engagers. AlloNK is currently in clinical trials in combination with rituximab for treatment of systemic lupus erythematosus (SLE) in patients with active lupus nephritis and for treatment of Non-Hodgkin Lymphoma, as well as in combination with Affimeds...

What are Artiva biotherapeutics's specialties? +

Cell therapy,cancer,nk cells,nk cell therapy,and car-nk

What is Artiva biotherapeutics's industry? +

Artiva biotherapeutics operates in the Biotechnology research industry.

What is Artiva biotherapeutics's revenue? +

Artiva biotherapeutics's revenue is 11m - 100m

What is Artiva biotherapeutics's company size? +

Artiva biotherapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.